Discontinuation report ACT RIZATRIPTAN

Last updated on 2021-07-22 History
Report ID 142912
Drug Identification Number 02381702
Brand name ACT RIZATRIPTAN
Common or Proper name ACT RIZATRIPTAN 10 MG TABLETS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 6's and 12's
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-07-15
Remaining supply date 2021-07-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments This product has transitioned to new Teva SKU no. 16821-10XX from 16823-10XX
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-07-22 French Compare
v1 2021-07-22 English Compare

Showing 1 to 2 of 2